Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| B (generally recommended) |
| Level of Evidence |
| well-designed NM recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Ankrah, A. O., Glaudemans, A. W. J. M., Maes, A., Van de Wiele, C., Dierckx, R. A. J. O., Vorster, M., & Sathekge, M. M. Tuberculosis. Semin Nucl Med....
read more
Ankrah, A. O., Glaudemans, A. W. J. M., Maes, A., Van de Wiele, C., Dierckx, R. A. J. O., Vorster, M., & Sathekge, M. M. Tuberculosis. Semin Nucl Med. 2018;. https://doi.org/10.1053/j.semnuclmed.2017.10.005.
Vorster, M., Sathekge, M. M., & Bomanji, J. Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT. Curr Opin Pulm Med. 2014; https://doi.org/10.1097/MCP.0000000000000043. Ankrah, A. O., van der Werf, T. S., de Vries, E. F., Dierckx, R. A., Sathekge, M. M., & Glaudemans, A. W. PET/CT imaging of Mycobacterium tuberculosis infection. Clin Transl Imaging. 2016; https://doi.org/ 10.1007/s40336-016-0164-0. Yu, W. Y., Lu, P. X., Assadi, M., Huang, X. L., Skrahin, A., Rosenthal, A., ... Wáng, Y. X. J. Updates on 18F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoring. Quant Imaging Med Surg. 2019; https://doi.org/10.21037/qims.2019.05.24. Kim, J. W., Munavvar, R., Kamil, A., & Haldar, P. PET-CT for characterising TB infection (TBI) in immunocompetent subjects: a systematic review. J Med Microbiol. 2023; https://doi.org/10.1099/jmm.0.001749. read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |